期刊文献+

SARS冠状病毒S2基因原核表达及免疫学特性 被引量:3

Prokaryotic expression of SARS-CoV S2 gene and preliminary study on its immune characteristics
下载PDF
导出
摘要 目的研究严重急性呼吸道综合征(SARS)冠状病毒S2蛋白表达并对其免疫学特性。方法克隆SARS冠状病毒S2基因,并在大肠埃希菌中表达谷胱甘肽硫转移酶(GST-S2)融合蛋白。通过免疫印迹(Westernblot)和酶联免疫吸附试验(ELISA)方法鉴定表达GST-S2融合蛋白的活性。结果通过原核系统表达的GST-S2融合蛋白可与谷胱甘肽硫转移酶(GST)多克隆抗体结合,并在85千道尔顿(KD)处出现特异性结合条带。GST-S2蛋白能与SARS患者恢复期血清反应,而不与正常人血清反应。结论本项研究获得了SARS冠状病毒GST-S2融合蛋白,它可与GST多克隆抗体特异性结合,并与SARS患者恢复期血清发生特异性反应。 Objective To express the SARS-CoV S2 protein in E coli and to study on its immune characteristics preliminarily. Methods SARS-CoV S2 gene was cloned and the GST-S2 fusion protein was expressed in E coli. The activity of the expressed GST-S2 fusion protein was identified by Western blot and enzyme linked immunosorbent assay (ELISA). Results Prokaryotie expressed GST-S2 fusion protein could bind the GST polyclone antibody and an 85KD immune band could be detected. Expressed GST-S2 protein bad response to convalescent serum from SARS patients, but not to control serum. Conclusion The obtained GST-S2 protein could be provided for the study on the infection process of host cells by SARS-CoV and the preparation of the recombination vaccine.
出处 《中国公共卫生》 CAS CSCD 北大核心 2007年第8期962-964,共3页 Chinese Journal of Public Health
基金 广东省科技攻关项目(532014202028) 广东省医药科研基金资助项目(A2004378)
关键词 SARS冠状病毒 S2基因 克隆 SARS-CoV S2 gene clone
  • 相关文献

参考文献8

  • 1Ksiazek TG,Erdonan D,Goldsmith CS,et al.A novel coronavirus associated with severe acute respiratory syndrome[J].N Engl J Med,2003,348(20):1953-1966.
  • 2Krueger DK,Kelly SM,Lewicki DN,et al.Variation in disparate regions of the murine coronavirus spike protein,the initiation of membrane fusion[J].Virol,2001,75(6):2792-2802.
  • 3彭莉,赵雨杰,王绍成,杨华,房凯,潘忠诚.SARS-CoV人工合成基因CAGZ的克隆和表达[J].中国公共卫生,2006,22(10):1249-1250. 被引量:1
  • 4胡族琼,赵卫,晏辉钧,张文炳,刘志伟,郭新雄,何凡,江丽芳,龙北国.SARS冠状病毒M基因变异规律分析[J].中国公共卫生,2005,21(12):1451-1452. 被引量:1
  • 5贡树基,赵卫,曹虹,张文炳,周浩,陈丽丹.登革2型病毒全长基因组的长链RT-PCR法扩增[J].中国公共卫生,2006,22(4):429-430. 被引量:6
  • 6Marra MA,Jones SJ,Astell CR,et al.The genome sequence of the SARS associated coronavirus[J].Science,2003,300(5624):1399-1404.
  • 7Fagchi F.The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding[J].J Virol,1995,69(10):7260-7263.
  • 8Y G,Zheng BJ,He YQ,et al.Isolation and characterization of viruses related to the SARS coronavirus from animals in southen China[J].Science,2003,302(5643):276-278.

二级参考文献18

  • 1贡树基,赵卫,曹虹.登革病毒感染实验室诊断的研究进展[J].中国人兽共患病杂志,2005,21(12):1103-1105. 被引量:6
  • 2De Haan CAM,Smeets M,Vernooij F,et al.Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein[J].J Virol,1999,73(9):7441-7452.
  • 3Kopecky SA,Willingham MC,Lyles DS.Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus[J].J Virol,2001,75(24):12169-12181.
  • 4Xue S,Jaszewski A,Perlman S.Identification of a CD4+ T cell epitope within the M protein of a neurotropic coronavirs[J].J Virol,1995,208(1):173-179.
  • 5He JF,Peng GW,Min J,et al.Molecular Evolution of the SARS Coronavirus During the Course of the SARS Epidemic in China[J].Science,2004,303(5664):1666-1669.
  • 6Yeh SH,Wang HY,Tsai CY,et al.Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan:Molecular epidemiology and genome evolution[J].PNAS,2004,101(8):2542-2547.
  • 7Ruan YJ,Wei CL,Ee LA,et al.Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection[J].Lancet,2003,361(9371):1779-1785.
  • 8Vaughn DW,Green S,Kalayanarooj S,et al.Dengue viremia titer,antibody response pattern,and virus serotype correlate with disease severity[J].J Infect Dis,2000,181(1):2-9.
  • 9Dar A,Munir S,Vishwanathan S,et al.Transcriptional analysis of avian embryonic tissues following infection with avian infectious bronchitis virus[J].Virus Res,2005,110(1-2):41-55.
  • 10Khatri M,Palmquist JM,Cha RM,et al.Infection and activation of bursal macrophages by virulent infectious bursal disease virus[ J ].Virus Res,2005,10:Epub ahead of print.

共引文献5

同被引文献23

  • 1王瑞琳,金宁一,金洪涛,张立树,郑敏,金明兰,屈勇刚.编码SARS-CoV S1和S2蛋白的DNA疫苗对小鼠的免疫应答[J].中国生物制品学杂志,2007,20(6):426-428. 被引量:1
  • 2Barry CE, Crick DC, McNeil MR. Targeting the formation of the cell wall core of M. tuberculosis[ J]. Infect Disord Drug Targets, 2007,7(2) :182-202.
  • 3Li W, Xin Y, McNeil MR,et al. rmlB and rmlC genes are essential for growth of mycobacteria [ J ]. Biochemical and BiophysicalResearch Communications,2006,342( 1 ) :170 - 178.
  • 4Berg S,Kaur D, Jackson M, et al. The glycosyltransfemses of Mycobacterium tuberculosis-roles in the synthesis of ambinogalactan, lipoambinomannan, and other glycoconjugates [ J ]. Glycobiology, 2007,17(6) :35 -56.
  • 5Mills JA,MotichkaK, Jucker M, et al. Inactivation of the mycobacterial rharnnosyltransferase, which is needed for the formation of the arabinogalactn-peptidoglycan linker, leads to irreversible loss of viability [J]. Journal of Biological Chemistry, 2004.279 (42 ):43540 - 43546.
  • 6Mikusova K, Belanova M, Kordulakova J, et al. Identification of novel galactosyl transferase involved in biosynthesis of the mycobacterial cell wall [ J ]. Journal of Bacteriology, 2006, 188 ( 18 ) :6592 -6598.
  • 7Carrio MM,Villaverde A. Construction and deconstruction of bacterial inclusion bodies [ J ]. Journal of Biotechnology, 2002,96 (1):3-12.
  • 8Ventura S. Sequence determinants of protein aggregation : tools to increase protein solubility [ J ]. Microbial Cell Factories, 2005,4 (1) :11 -19.
  • 9Clark EB. Protein refolding for industrial processes[ J]. Current Opinion in Biotechnology ,2001,12 (2) :202 - 207.
  • 10Bartlam M,Yang HT,Rao ZH.Structural insights into SARS coronavirus proteins[J].Curr Opin Struct Biol,2005,15(6):664.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部